All Videos

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, talk about the use of oral systemic agents and what they’ve learned about the patient experience from the use of these agents.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, examine the clinical context for the approval of topical ruxolitinib and its role in the treatment armamentarium.

Mark G. Lebwohl, MD, introduces the case of a 28-year-old female nurse with a long history of psoriasis, commenting on her past medical history and initial presentation.

Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss the durability of IL-17 inhibitors in managing plaque psoriasis.

Expert dermatologists discuss how to select treatment for plaque psoriasis while taking comorbidities into consideration.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses a rare form of skin cancer, Merkel cell carcinoma.

Thought leaders discuss why JAK inhibitors are well suited for the management of itch and inflammation in the treatment of moderate to severe atopic dermatitis.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the recent trajectory of the atopic dermatitis therapeutic spectrum, notably how several newer approvals have changed how clinicians approach treatment.

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss how to select treatment for plaque psoriasis based on mechanism of action.

Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss pathogenesis of plaque psoriasis and new emerging targets.

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the social media phenomenon of "dermarolling."

Christopher Bunick, MD, PhD, discusses the 5th personal care product category recall, dry shampoos, due to heightened levels of benzene.

Neal D. Bhatia, MD, discusses the nuances of photodynamic therapy in a session at Fall Clinical in Las Vegas, Nevada, October 20-23.

Data demonstrates an increase in the proportion of patients achieving regimentation with longer duration of ruxolitinib cream treatment.

At the 2022 Fall Clinical Conference in Las Vegas, Nevada, Dermatology Times editor-in-chief, Zoe Diana Draelos, discusses her session on the latest trends in cosmeceuticals.

As the 2022 Fall Clinical Dermatology Conference begins this week, Heathy Ivy, DO, regional medical director for LaserAway in Atlanta, Georgia, shares why she is looking forward to attending Fall Clinical.

Matt Leavitt, DO, FAOCD, discusses highlights of his session on "Evalulating the Patient With Hair Loss" at this year's Fall Clinical conference in Las Vegas Nevada, October 20-23.

Raj Chovatiya, MD, PhD, assistant professor of dermatology and Medical Director, Center for Eczema and Itch and Medical Director, Clinical Trials Unit at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, shares highlights from his upcoming presentations at Fall Clinical in Las Vegas, Nevada, October 20-23, 2022.

Lisa Swanson, MD, FAAD, a pediatric dermatologist in Boise, Idaho, presents all that is new and hot in pediatric dermatology at the 2022 Fall Clinical Conference in Las Vegas Nevada, October 20-23.

Christopher Bunick, MD, shares highlights of his session from the 2022 Fall Clinical conference in Las Vegas, Nevada, October 20-23.

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.

Mark G. Lebwohl, MD, presents a case of a 45-year-old Caucasian male diagnosed with psoriasis.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses holistic medicine vs. western medicine for eczema treatment.

Drs Mark G. Lebwohl and Joseph F. Merola discuss the use of biosimilars in psoriasis and how biosimilars will change the treatment landscape.

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide insight on when it is appropriate to switch from one biologic to another for a patient with psoriasis.

The legacy of the late Vic Narurkar, MD, and his commitment to aesthetics was honored at the 2022 Annual ASDS Meeting.

At the 2022 Annual ASDS Meeting, Mona Gohara, MD, highlights the importance of diversity, equity, and inclusion in the field of dermatology.

Sherrif Ibrahim, MD, PhD, provides key pearls from his co-directed session at the 2022 Annual ASDS Meeting, “Defining ‘High-Risk’ for Squamous Cell Carcinoma: Implications for Treatment Paradigms.”

Mona Gohara, MD, gives an overview and 3 highlights from her presentation, “How to Build and Design a Dermatologic Practice,” at the 2022 ASDS Annual Meeting.

Patricia Farris, MD, dermatologist from Metairie, Louisiana, discusses key pearls from her presentation at the American Society for Dermatologic Surgery (ASDS) Meeting.